Bupropion for the treatment of apathy in Huntington's disease: A multicenter, randomised, double-blind, placebo-controlled, prospective crossover trial. (2017)

First Author: Gelderblom H

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1371/journal.pone.0173872

PubMed Identifier: 28323838

Publication URI: http://europepmc.org/abstract/MED/28323838

Type: Journal Article/Review

Volume: 12

Parent Publication: PloS one

Issue: 3

ISSN: 1932-6203